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Abstract
Background: Kidney transplant recipients are recognized as a vulnerable population that is at increased risk of
adverse health outcomes. However, there have been few studies that have compared hospital-related morbidity of
these patients to the general population, and how this differs with respect to time since transplantation. Such
analyses are useful in estimating the health burden in this patient population.
Methods: We assembled a population-based Canadian cohort (excluding Quebec) of 6,116 kidney transplant
recipients who underwent transplantation between 1 April 2001 and 31 December 2008. Record linkage was used
to identify hospital discharge records of these patients from 1 April 2001 through 31 March 2009. Hospital
discharges were tabulated across the main disease chapters of the ICD10, and person-years of follow-up were
calculated across age and sex strata. Comparisons of hospital-related morbidity to the general population were
made by using a standardized hospitalization ratio (SHR). For those who underwent transplantation in 2004,
stratified analyses were performed to explore differences in hospital discharge rates both before and after
transplantation.
Results: After excluding hospitalizations due to complications from transplantation, when compared to the general
population, transplant recipients were approximately 6.4 (95% CI: 6.3, 6.5) times more likely to be hospitalized
during follow-up. The SHRs were highest during the time periods proximate to transplantation, and then decreased
to approximately a five-fold increase from 3 years post transplantation onwards. The largest disease-specific
excesses were observed with infectious diseases and diseases of the endocrine system. Among those who
underwent transplantation in 2004, the SHR decreased from 11.2 to 5.0 in the periods before and after surgery,
respectively.
Conclusions: Our results indicate that, even more than 5-years post transplantation, there remains a more than
six-fold difference in hospitalization rates relative to the general population. Additional work is needed to confirm
these findings, and to develop strategies to reduce long-term morbidity in this patient population.
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Background
In Canada, the prevalence of end-stage renal disease has
increased steadily over the past 20 years [1-3]. Kidney
transplantation is the preferred treatment among individ-
uals with end-stage renal disease, and improvements in
treatment have produced a 1-year survival probability fol-
lowing transplantation that now exceeds 90% [4]. Improved
survival implies a substantially increased opportunity to ex-
perience adverse health events post transplantation. Kidney
transplant recipients have higher incidence rates of cancer,
particularly non-Hodgkin’s lymphoma and skin cancer
when compared to the general population [5,6]. These re-
cipients are also more likely to be at an increased risk of
developing cardiovascular disease [7,8], diabetes mellitus
[9,10], fractures [11-13], and infection [14] post transplant-
ation. In addition, some have recently suggested that trans-
plant patients are more likely than the general population
to have higher rates of depression or other psychiatric
illnesses [15,16].
To date, there have been relatively few studies that
have evaluated the long-term hospitalization patterns
among kidney transplant patients. Those that have were
typically single-center studies that have been focused on
specific diseases and were based on relatively small
numbers of transplant patients [9,13,15]. Hospitalization
admissions patterns have previously been evaluated
using data from the Dialysis Outcomes and Practice
Patterns Study (DOPPS) that examined hospital admis-
sions among dialysis patients. Unfortunately these ana-
lyses excluded transplant patients [17]. Another study
[18] based on US transplant patients was more focused
on statistical methods and did not provide comparisons
to the general population. In our view, there is insuffi-
cient information to adequately characterize the long-
term hospitalization burden in the post-transplant renal
recipient.
This study aims to address two important research
questions that remain unanswered. First, to what extent
does transplantation reduce hospital-related morbidity
among kidney transplant recipients post transplantation;
and second, does the increased need for hospitalization
among transplant recipients change with increasing time
since transplantation? We used two population-based
administrative datasets to create a longitudinal dataset
that allows these research questions to be addressed.
Methods
Study population
Our study cohort was created by abstracting data from a
national information system for renal and extra-renal
organ failure and transplantation in Canada, the Canadian
Organ Replacement Registry (CORR), which is maintained
by the Canadian Institute for Health Information (CIHI).
Data are provided to the CORR from all 27 kidney
transplant programs across Canada. It has been estimated
that the CORR covers approximate 99% of all transplant
patients in Canada [19]. Patients included in this analysis
consisted of those in the CORR database who underwent
renal transplantation between 1 April 2001 and 31 De-
cember 2008. We restricted analyses to records that repre-
sented an individual’s first transplantation. Patients who
underwent more than one kidney transplantation were ex-
cluded from analysis. Individual-level variables extracted
from the CORR included date of birth, gender, province of
residence, and vital status.
Ascertainment of hospital admissions
The hospitalization experience of the cohort members was
determined by linking the personal identifiable data from
the CORR to information from the Canadian Discharge
Abstract Database (DAD) [20]. The DAD is a population-
based database that contains information on all separa-
tions from acute care institutions, including discharges,
deaths, sign-outs, and transfers (excluding Quebec). It has
been estimated that the DAD captures >95% of all
hospitalization in Canada (excluding Quebec).
The DAD and CORR record linkage process generated
an analysis dataset for the time period between 1 April
2001 and 31 March 2009 identifying hospital discharges
among the renal transplant patients. The Most Respon-
sible Diagnosis was used at the time of hospital dis-
charge to classify morbidity among the study population.
Hospital admissions were classified based on Inter-
national Classification of Diseases-10 version (ICD10)
chapter definitions [21]. Since DAD does not capture in-
formation in Quebec, all records from Quebec in CORR
were also excluded for the linkage and analysis.
Since hospitalization during the first couple of months
after renal transplant likely reflects morbidity related to
the transplant procedure itself, the follow-up interval
within the first 60 days after the procedure was exam-
ined separately. Initially, a total of 6,116 renal transplant
recipients who underwent transplantation between 1
April 2001 and 31 December 2008 were identified.
Patients who ended the follow-up within the first 60
days after transplant (n=37) were analyzed only for the
short-term follow-up in the study. In summary, our risk
estimates for medium- and long-term hospital utilization
were based on 6,079 renal transplant patients. All trans-
plant patients were followed up until either death
(between 1 April 2001 and 31 March 2009) or the end
of the study (31 March 2009).
Statistical analysis
Person-years of follow-up and the number of hospitali-
zations were tabulated across strata defined by: 5-year
age-group, sex (male, female), length of follow-up (<60
days, 60 days to <3 years, 3 years to <5 years, and 5
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years and over), and calendar year (2001 to 2008). The
DATAB module in the Epicure software program was
used to tabulate these person-years [22]. Hospital dis-
charge rates for the Canadian general population exclude
Quebec were also obtained from the DAD, and were
computed across the same age-group and sex strata.
Hospital discharge rates for the kidney transplant co-
hort were compared to those of the general population
using the Standardized Hospitalization Ratio (SHR). The
SHR represents the ratio of observed-to-expected num-
bers of hospital admissions, with the ‘expected’ reflecting
the number of hospitalizations that would be expected
in the transplant cohort if it had the same age-sex spe-
cific hospital discharge rates as the general population.
The 95% confidence intervals (CIs) for the SHRs were
constructed using the normal approximation [23].
Disease categories for complications of procedures/
transplanted organs rejection, follow-up examination
and adjustment, and other supplementary classifications
related to transplant procedure (ICD-10 codes: S01-T99,
V01-Y98, and Z00-Z99) were investigated separately and
not included in the SHRs comparison. Statistical signifi-
cance was determined based on a two-tailed alpha of
5%. To adjust for differences in the sex and length of
follow-up distribution, the stratified SHRs were also cal-
culated. Analyses were repeated for each of the following
main disease categories comprising the ICD-10. The
proportions of hospital admission on major disease cat-
egory were calculated by length of follow-up and com-
pared to those in the general population.
To evaluate whether transplantation reduced morbidity,
we conducted a period-rates comparison among individ-
uals having sufficient follow-up time both before and after
surgery. Specifically, among kidney transplant recipients
who underwent transplantation between 1 April 2004 and
31 March 2005 we compared the SHRs in the pre-
transplant (1 April 2001 to 31 March 2003) and post-
transplant periods (1 April 2006 to 31 March 2008).
Results and discussion
Results
Descriptive statistics
The basic statistics for the study cohort are provided in
Table 1. The cohort consisted of 6,116 renal failure pa-
tients who underwent transplantation between 1 April
2001 and 31 December 2008. The mean age of the recip-
ients was 47.2 years, and the 25th and 75th age percen-
tiles were 37.2 and 58.8, respectively. Approximately
62% of the cohort was male. In total, 22,619.3 person-
years were accrued between the date of transplantation
and the end of follow-up. Approximately 8% of the co-
hort (n=482) was deceased at the end of the follow-up
interval, of which 37 patients died between within the
first 60 days post transplant. In the study, 6,079 patients
were followed-up for post-transplant hospital admissions
commencing 60 days after the transplant.
Hospital admission rates
A total of 17,431 hospitalizations were observed among
the kidney transplant recipients over the follow-up inter-
val. After excluding patients with <60 days of follow-up
and hospitalization for transplant procedure related
causes, the total number of hospital admissions in this
cohort was 14,147. The SHR was 6.4 relative to the
Canadian general population, with similar ratios for men
and women (male: SHR=6.2; female: SHR=6.5). Among
disease categories, SHRs were most elevated for infectious
diseases, endocrine disorders, and congenital anomalies.
Complications of pregnancy in women was the only
condition for which the hospitalization rates were lower
among the kidney transplant patients relative to the
general population (SHR=0.2) (Table 2).
Table 1 Descriptive characteristics of kidney transplant
recipients in the Canadian Organ Replacement Registry
(excluding Quebec) undergoing transplantation between
April 2001 and December 2008
Characteristic Patients (n) %
Sex
Male 3,779 61.8
Female 2,337 38.2
Age at transplant (years)
<15 213 3.5
15 to <40 1,600 26.2
40 to <55 2,139 35.0
55 to < 70 1,905 31.1
70 and over 259 4.2
Total length of follow-up
< 60 daysa 37 0.6
60 days to < 3 years 2,588 42.3
3 years to < 5 years 1,538 25.2
5 years and over 1,953 31.9
Year of renal transplant
2001 538 8.8
2002 712 11.6
2003 719 11.8
2004 728 11.9
2005 762 12.4
2006 879 14.4
2007 904 14.8
2008 874 14.3
Total (excluding the first 60 days) 6,079 99.4
Total 6,116 100.0
aThese subjects were excluded in the estimation of hospitalization.
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During the first 60 days after the transplant procedure,
60% of hospital admissions were attributable to the pro-
cedure itself or to related causes which included compli-
cations of procedure, transplanted organs rejection, and
follow-up examination and other factors influencing
health status (Table 3). This decreased to 30% thereafter.
After excluding procedure-related causes, during the
first 60 days post transplant, the patient cohort experi-
enced higher standardized hospitalization ratios due to
infectious disease, endocrine and genitourinary disease,
and lower SHRs for neoplasms and circulatory disease.
In the long-term follow-up analysis the proportions of
hospital admission of major causes of disease, such as
circulatory disease and respiratory disease, tended to
return closely to those in the general population (data
not shown). There were significant differences on hos-
pital admission rates by province during the follow-up
periods. Between 2006 and 2008, the SHR in Ontario
was 380/100,000 person-years which was significantly
lower than British Columbia (508/100,000 person-years)
and that of the Atlantic region (NB 583/100,000 person-
years, NS 633/100,000 person-years, and NL 795/
100,000 person-years).
In Table 3 SHRs of hospital admissions decreased by
time since transplantation. In general, the highest SHR
was observed in the period immediately after transplant
procedure (<60 days); then it decreased and stabilized
after 3 years post transplant. Excluding hospitalization
<60 days after transplantation disease-specific SHRs
were the highest for infectious diseases (SHR=38.9; 95%
CI=36.0-42.0) and endocrine disorders (SHR=25.3, 95%
CI=23.5-27.1). It is worth noting that the SHRs of infec-
tious diseases and genitourinary diseases were extremely
high, but decreased rapidly, while the SHRs for neo-
plasms and circulatory diseases were relatively stable
throughout the follow-up intervals (3.0 and 4.5, respect-
ively), excluding the fellow-up period of <60 days.
Figure 1 displays trends in the hospitalization rates by
follow-up period. The highest hospitalization rates were
in the first year of follow-up post transplant. After the
first year, SHRs decreased considerably for the next 2 to
3 years of follow-up. After 3 to 4 years post transplant,
hospitalization rates appeared to level off, and remained
stable for the rest of the follow-up period. Figure 2
reveals that such trends were very similar when analyzed
separately by age group.
Morbidity impact on transplant procedure
Table 4 provided hospital admission rates and SHRs of
both pre- (1 April 2001 to 31 March 2003) and post-
(1 April 2006 to 31 March 2008) transplant periods
among patients who underwent transplantation in 2004.
Table 2 Number of hospitalizations and standardized hospitalization ratios (SHRs) relative to the general population
among 6,079 kidney transplant patients, between April 2001 and December 2008, by disease categorya
Disease grouping ICD10b Kidney transplant patients
Observed Expected SHR 95% CI
All hospitalizations 14,147 1,876.1 7.5 7.4, 7.7
All hospitalizationsc Excluding S01-T99, V01-Y98, and Z00-Z99 10,227 1,604.6 6.4 6.3, 6.5
Infectious diseases A00-B99 853 27.4 31.2 29.1, 33.4
Neoplasms C00-D48 498 171.2 2.9 2.7, 3.2
Blood disorders D50-D89 201 16.5 12.2 10.6, 14.0
Endocrine disorders E00-E99 1,114 50.6 22.0 20.7, 23.3
Mental disorders F00-F99 80 84.7 0.9 0.7, 1.2
Nervous system and sense organs G00-G99, H00-H95 483 43.2 11.2 10.2, 12.2
Circulatory I00-I99 1,078 298.6 3.6 3.4, 3.8
Respiratory J00-J99 661 123.4 5.4 4.9, 5.8
Digestive K00-K93 1,480 227.0 6.5 6.2, 6.9
Skin and subcutaneous tissue L00-L99 165 19.9 8.3 7.1, 9.7
Musculoskeletal M00-M99 420 128.8 3.3 3.0, 3.6
Genitourinary N00-N99 2,132 120.2 17.7 17.0, 18.5
Complications of pregnancy O00-O99 38 158.2 0.2 0.2, 0.3
Congenital anomalies Q00-Q99 53 2.8 18.9 14.2, 24.8
Symptoms ill defined R00-R99 968 114.6 8.4 7.9, 9.0
aFollow-up interval was from 60 days after the date of their renal transplant to the date of death or until 31 March 2009.
bICD 10, International Classification of Diseases, 10th.
cDisease category on complications of procedures/ transplanted organs rejection, follow-up examination and adjustment, and other supplementary classifications
related to transplant procedure (ICD-10 codes: S01-T99, V01-Y98, and Z00-Z99) was excluded.
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The overall pre-transplant hospital admission rate was
11 times higher than that of the general population
while the post-transplant hospital admission rate was 5
times higher. The disease specific statistics shown the
SHRs had reduced from 61 to 3 for blood disorders, 57
to 17 for endocrine disorders, 14 to 4 for circulatory
diseases, and 43 to 13 for genitourinary diseases. In gen-
eral, the post-transplant admission rate was about 40%
of the pre-transplant hospital rate. With the exceptions
of admissions for infection, neoplasms, and respiratory
diseases, transplant patients had much lower hospital
admission rates post transplantation compared to pre
transplantation, especially for blood disorders, endocrine
disorders, and circulatory and genitourinary diseases.
Discussion
This study found that kidney transplant recipients had
higher hospital admission rates both overall and for
many different disease groupings when compared to the
general population. These results are consistent across
the entire cohort and all the subgroup analyses. A simi-
lar observation of higher rates of hospitalization among
kidney transplant recipients has been noted by Boubaker
et al. who also reported that the most common causes of
hospitalization in their study were infections and renal
dysfunction [24]. Abbott el al. noted that renal trans-
plant recipients were at high risk for hospitalizations for
cytomegalovirus disease and fractures [25,26].
Table 3 SHRs for hospitalizations among kidney transplant patients relative to the Canadian general population, by
time since transplantation, 2000 to 2008a
Disease grouping Time since transplantation
0 days to < 60 days 60 days to <3 years 3 to <5 years 5 years or over
Ob SHR (95% CI) O SHR (95% CI) O SHR (95% CI) O SHR (95% CI)
All hospitalizations 3,284 40.1 (38.7, 41.5) 10,063 8.8 (8.7, 9.0) 2,609 5.5 (5.3, 5.7) 1,475 5.6 (5.3, 5.9)
All hospitalizations excluded ICD-10:
S01-T99, V01-Y98, and Z00-Z99c
1,371 19.6 (18.6, 20.7) 7,015 7.2 (7.1, 7.4) 2,044 5.0 (4.8, 5.2) 1,165 5.2 (4.9, 5.5)
Infectious diseases 111 92.5 (76.1, 111.4) 648 38.9 (36.0, 42.0) 124 18.0 (14.9, 21.4) 81 20.8 (16.5, 25.8)
Neoplasms 6 0.8 (0.3, 1.8) 320 3.1 (2.8, 3.5) 105 2.4 (2.0, 2.9) 73 3.0 (2.3, 3.8)
Blood disorders 27 38.6 (25.4, 56.1) 165 17.4 (14.8, 20.2) 24 6.0 (3.8, 8.9) 12 5.5 (2.8, 9.5)
Endocrine disorders 148 67.3 (56.9, 79.0) 773 25.3 (23.5, 27.1) 239 18.5 (16.3, 21.0) 102 14.4 (11.7, 17.4)
Mental disorders 9 2.3 (1.1, 4.4) 43 0.8 (0.6, 1.1) 21 1.0 (0.6, 1.5) 16 1.5 (0.8, 2.4)
Nervous system and sense organs 16 8.4 (4.8, 13.7) 311 11.9 (10.6, 13.3) 112 10.3 (8.5, 12.4) 60 10.0 (7.6, 12.9)
Circulatory 179 14.3 (12.3, 16.6) 633 3.6 (3.3, 3.8) 247 3.2 (2.8, 3.6) 198 4.5 (3.9, 5.2)
Respiratory 31 6.0 (4.0, 8.5) 400 5.4 (4.9, 6.0) 167 5.3 (4.5, 6.2) 94 5.2 (4.2, 6.3)
Digestive 172 17.2 (14.7, 20.0) 1,032 7.5 (7.0, 7.9) 277 4.8 (4.3, 5.4) 171 5.5 (4.7, 6.3)
Skin and subcutaneous tissue 7 7.8 (3.1, 16.0) 103 8.4 (6.9, 10.2) 39 7.8 (5.5, 10.7) 23 8.5 (5.4, 12.8)
Musculoskeletal 18 3.3 (1.9, 5.2) 261 3.4 (3.0, 3.8) 109 3.3 (2.7, 4.0) 50 2.7 (2.0, 3.6)
Genitourinary 411 79.0 (71.6, 87.1) 1,577 21.7 (20.6, 22.8) 375 12.3 (11.1, 13.6) 180 10.6 (9.2, 12.3)
Complications of pregnancy 0 n/a 19 0.2 (0.1, 0.3) 14 0.4 (0.2, 0.6) 5 0.2 (0.1, 0.6)
Congenital anomalies 8 80.0 (34.4, 157.6) 33 22.0 (15.1, 30.9) 13 21.7 (11.5, 37.1) 7 23.3 (9.3, 48.1)
Symptoms ill defined 228 46.5 (40.7, 53.0) 697 10.1 (9.4, 10.9) 178 6.1 (5.2, 7.1) 93 5.7 (4.6, 7.0)
aIndividuals were followed up from the date of their renal transplant until the date of death or 31 March 2009.
bO Observed.
cDisease category on complications of procedures/transplanted organs rejection, follow-up examination and adjustment, and other supplementary classifications
related to transplant procedure (ICD-10 codes: S01-T99, V01-Y98, and Z00-Z99) was excluded.
Figure 1 SHRs by follow-up period among kidney transplant
patients, 2001 April to 2009 March, Canada.
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Figure 2 Hospitalization rates by follow-up period among kidney transplant patients, 2001 April to 2009 March, Canada.
Table 4 Pre- and post-transplantation hospital admission rates comparison among 728 kidney transplant recipients,
2004
Disease grouping General
population
hospital
admission rate
Pre-transplant hospital
admission rate (n) (April
2001 to March 2003)
Pre-transplant/
general
population
Post-transplant
hospital admission
rate (n) (April 2006
to March 2008)
Post-transplant/
general
population
Post-transplant/
Pre-transplant
All hospitalizations 79.8 1,091.3 (1589) 13.7 436.1 (635) 5.5 0.4
All hospitalizations
excluded ICD-10:
S01-T99, V01-Y98,
and Z00-Z99
68.1 762.4 (1110) 11.2 337.9 (492) 5.0 0.4
Infectious diseases 1.4 15.8 (23) 11.3 20.6 (30) 14.7 1.3
Neoplasms 5.7 16.5 (24) 2.9 22.0 (32) 3.9 1.3
Blood disorders 0.7 42.6 (62) 60.9 2.1 (3) 3.0 0.1
Endocrine disorders 2.0 114.0 (166) 57.0 33.7 (49) 16.9 0.3
Mental disorders 3.9 4.1 (6) 1.1 2.1 (3) 0.5 0.5
Nervous system and
sense organs
1.8 30.9 (45) 17.2 15.1 (22) 8.4 0.5
Circulatory 9.7 131.9 (192) 13.6 39.1 (57) 4.0 0.3
Respiratory 6.3 24.7 (36) 3.9 29.5 (43) 4.7 1.2
Digestive 8.8 96.8 (141) 11.0 61.8 (90) 7.0 0.6
Skin and subcutaneous
tissue
0.8 7.6 (11) 9.5 4.8 (7) 6.0 0.6
Musculoskeletal 4.5 27.5 (40) 6.1 11.7 (17) 2.6 0.4
Genitourinary 4.7 199.9 (291) 42.5 61.1 (89) 13.0 0.3
Complications of
pregnancy
12.1 6.2 (9) 0.5 2.7 (4) 0.2 0.4
Congenital anomalies 0.4 11.7 (17) 29.3 0.7 (1) 1.8 0.1
Symptoms ill defined 4.7 31.6 (46) 6.7 30.9 (45) 6.6 1.0
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In this patient cohort, the two most common causes of
hospitalization were infectious diseases and endocrine dis-
orders. This finding is consistent with other studies
[14,24,27,28]. However, over the follow-up period of the
study, the hospitalizations for these diseases have de-
creased greatly. For example, the incidence of infection
has dropped from approximately 70% to between 15% and
44% [14]. In our study, except for the first 60 days after a
transplant procedure, close to 6% of total hospitalization
was associated with infection through the study period.
These reductions might be due to recent improvements in
surgical techniques, immunosuppressive drugs, methods
of diagnosis, and therapy. Urinary tract infection is the
most common form of infection, and occurs in approxi-
mately 30% of patients within the first 3 months following
transplantation [29]. Cytomegalovirus (CMV) is also a
common infection among renal transplant patients [26].
The sole exception of an increased SHR was hospi-
talization due to complications of pregnancy which was
likely due a much lower predisposition of transplant pa-
tients to become pregnant as these patients are likely older
and may already have children or not want to become
pregnant. Hospitalizations due to endocrine disorders are
likely due to diabetes, a known complication of treatment
with steroids. However the data are not granular enough
to permit this to be ascertained.
The finding of the highest risk of hospital admission
among those follow-up <60 days is not unexpected. This
is likely related to the transplant procedure itself in
addition to increased intensity of immune suppression
during this period. Thereafter, SHR decreased over time,
with a stable five-fold increased risk relative to the gen-
eral population achieved at 3 years post transplant. The
differences in hospitalization rates by province in par-
ticular between Ontario and BC or Atlantic region may
be related to their follow-up care provision after trans-
plant. In BC and Atlantic Canada patients are discharged
to the community, and in the rest of the country (in-
cluding Ontario) most care continues to be provided by
the transplant centers.
Given the high quality and completeness in both
CORR and DAD, it is reasonable to assume that losses
to follow-up and primary diagnostic misclassification
were low. As mentioned it has been estimated that <5%
of hospital admissions would be missed across Canada
(except Quebec), and therefore, the overall bias on the
analysis should not be common. It is possible patients
would be lost to follow-up if they moved outside the
country after transplant procedure. However, given the
medical needs of the kidney transplantation patients and
the healthcare services provided within Canada, this
number would be minimal.
Patients who underwent transplantation in 2004 could
provide 2 years of hospital admission data for both pre
transplant (2001 to 2003) and post transplant (2006 to
2008), allowing for a comparison of hospital admission
between pre and post transplant except transplant pro-
cedure. The SHR decreased considerably pre to post
transplant, from nearly 11 to approximately 5 suggesting
that their overall health status improved significantly.
Caution should be exercised in interpreting the SHRs
in this study. First, the DAD is an administrative data-
base which only captures hospitalizations where patients
were formally admitted to hospital and only those condi-
tions severe enough to require hospitalization. It is un-
able to capture the morbidity among kidney transplant
patients associated with increased visits to emergency
departments where they are treated on an outpatient
basis, or increased physician or prescription drug utili-
zation. Second, biases may have been introduced from
the patient selection process for transplantation. The se-
lection criterion would differ by individual, and may re-
flect either a patient with optimum access to or with the
most need for a transplant, or in sufficiently good health
to be able to undergo transplantation. Since there is no
patient level information on the criteria used to identify
who underwent transplantation, the magnitude and the
direction of the bias are unknown.
Conclusions
In summary, the present study confirmed and quantified
kidney transplant patients’ much higher rates of
hospitalization in reference to the general population.
The highest cause specific excesses were from infectious
diseases and endocrine disorders. Hospital admissions
among the patient cohort decreased by time after trans-
plant and reached equilibrium at 3 years. Subsequently,
the post-transplant patients had a relative risk for
hospitalization approximately 5 times than of the general
population. These results may help guide the formula-
tion and implementation of preventive programs after
the transplant procedure.
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